Kinetic Discovery
Drug discovery services as hit identification, confirmation and validation.
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | - | - |
| % growth | - | (11 %) | (89 %) | (86 %) | - | - |
| EBITDA | <1m | (<1m) | (<1m) | <1m | (<1m) | (<1m) |
| % EBITDA margin | 53 % | (17 %) | (28 %) | 55 % | - | - |
| Profit | <1m | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) |
| % profit margin | 41 % | (18 %) | (15 %) | (131 %) | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Growth Equity VC | ||
N/A | Acquisition | ||
| Total Funding | - | ||
Recent News about Kinetic Discovery
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.